NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
GUFIC BIOSCIENCES LTD. (BSE: 509079)
509079 Technical Analysis
5
As on 24th Dec 2024 509079 SHARE Price closed @ 443.35 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 310.16 & Strong Buy for SHORT-TERM with Stoploss of 337.23 we also expect STOCK to react on Following IMPORTANT LEVELS. |
509079SHARE Price
Open | 446.70 | Change | Price | % |
High | 446.70 | 1 Day | 11.45 | 2.65 |
Low | 428.00 | 1 Week | 78.35 | 21.47 |
Close | 443.35 | 1 Month | 78.35 | 21.47 |
Volume | 3282 | 1 Year | 120.25 | 37.22 |
52 Week High 446.70 | 52 Week Low 278.00 |
BSE INDIA Most Active Stocks
532822 | 7.47 | -0.13% |
532411 | 0.41 | 0.00% |
517001 | 0.09 | 12.50% |
511700 | 1.01 | -0.98% |
512149 | 0.88 | 0.00% |
511389 | 7.25 | -2.42% |
534690 | 7.65 | 4.79% |
532775 | 2.04 | -0.97% |
531328 | 1.05 | 0.96% |
532648 | 19.80 | -0.60% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
509079 Daily Charts |
509079 Intraday Charts |
Whats New @ Bazaartrend |
509079 Free Analysis |
|
509079 Important Levels Intraday
RESISTANCE | 479.38 |
RESISTANCE | 467.83 |
RESISTANCE | 460.68 |
RESISTANCE | 453.54 |
SUPPORT | 433.16 |
SUPPORT | 426.02 |
SUPPORT | 418.87 |
SUPPORT | 407.32 |
509079 Target May 2025
4th UP Target | 0 |
3rd UP Target | 0 |
2nd UP Target | 0 |
1st UP Target | 0 |
1st DOWN Target | 0 |
2nd DOWN Target | 0 |
3rd DOWN Target | 0 |
4th DOWN Target | 0 |
509079 Weekly Target
4th UP Target | 0.00 |
3rd UP Target | 0.00 |
2nd UP Target | 0.00 |
1st UP Target | 0.00 |
1st DOWN Target | 0.00 |
2nd DOWN Target | 0.00 |
3rd DOWN Target | 0.00 |
4th DOWN Target | 0.00 |
509079 Target2025
4th UP Target | 644.82 |
3rd UP Target | 539.21 |
2nd UP Target | 473.92 |
1st UP Target | 408.64 |
1st DOWN Target | 222.36 |
2nd DOWN Target | 157.08 |
3rd DOWN Target | 91.79 |
4th DOWN Target | -13.82 |
GUFIC BIOSCIENCES LTD. ( BSE INDIA Symbol : 509079 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
509079 Other Details
Segment | EQ | |
Market Capital | 6950219264.00 | |
Sector | Healthcare | |
Industry | Drugs - Generic | |
Offical website | > echo $website ; ?> |
509079 Address
![]() |
509079 Latest News
509079 Business Profile
Gufic Biosciences Limited engages in the manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anaesthetics, and immuno suppressants, as well as intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products. The company was founded in 1970 and is based in Mumbai, India. Address: SM House, Mumbai, India, 400057
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service